Cluster headache in adults

Research output: Contribution to journalArticleOtherpeer-review

2 Citations (Scopus)

Abstract

Cluster headache is characterised by attacks of very severe, unilateral headache lasting 15–180 minutes, up to eight times per day. The attacks are associated with cranial autonomic symptoms on the same side and a sense of agitation or restlessness. First-line acute abortive treatments include intranasal or subcutaneous sumatriptan or high-flow oxygen. Neuromodulation may benefit some patients. First-line preventive therapy is high-dose verapamil. Close monitoring is required for the adverse effect of arrhythmia. There are several emerging therapies that have either proven efficacy, or possible benefit for cluster headache. They include drugs aimed at the calcitonin gene-related peptide.

Original languageEnglish
Pages (from-to)15-20
Number of pages6
JournalAustralian Prescriber
Volume45
Issue number1
DOIs
Publication statusPublished - Feb 2022

Keywords

  • calcitonin gene-related peptide
  • cluster headache
  • trigeminal autonomic cephalalgias
  • triptans

Cite this